Table 3.

Reg‐2, C16 and Ang‐1 treatments reduced c‐SEP latencies and increased c‐SEP amplitudes

8 weeks	Latency (ms)
Group	N	P	Wave amplitude (μV mean ± SD)
Normal	17.2 ± 0.23a	19.67 ± 0.10b	21.76 ± 1.44b
Vehicle	23.45 ± 0.34	29.65 ± 0.21	4.36 ± 1.01
Reg‐2	17.68 ± 0.35a	20.12 ± 0.56b	8.91 ± 1.23b
C+A	16.24 ± 0.27a	19.48 ± 0.45b	9.23 ± 0.88b
C+A+R	15.79 ± 0.99b	20.32 ± 0.67b	20.33 ± 0.78b

N, negative deflection; P, positive deflection.

^a P < 0.05 vs. vehicle‐treated EAE rats at 8 weeks post‐immunization.

^b P < 0.01 vs. vehicle‐treated EAE rats.